PureTech’s Gallop Maintains Steady Gait In MDS After Strong Showing For LYT-200

 
• By Alaric DeArment
  
Horses
PureTech's Gallop announced results from its Phase Ib trial of LYT-200 in MDS and AML. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Commercial Strategy

More from Business